Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
JCO Clinical Cancer Informatics|January 29, 2021
Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in BAP1 Pathogenic Variant CarriersSebastian Walpole, Nicholas K Hayward, Antonia L Pritchard, et al.JMIR Dermatology|August 26, 2023
Assessing Sunscreen Protection Using UV Photography: Descriptive StudyCaitlin Horsham, Helen Ford, Jeremy Herbert, et al.Clinical Genetics|November 24, 2025
Functional Analysis and Clinical Data Reclassify the DICER1 c.4206+1G>C Variant, Leading to Exon 22 Skipping, as Likely PathogenicSebastian Walpole, Miren Itxaso Santiago-Vela, Ulf Birkedal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In VivoZay Yar Oo, Alexander J Stevenson, Martina Proctor, et al.Molecular Oncology|May 3, 2019
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabineZay Yar Oo, Martina Proctor, Alexander J Stevenson, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 24, 2022
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 MutationsMichele Carbone, Harvey I Pass, Guntulu Ak, et al.Journal of the National Cancer Institute|December 6, 2018
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families WorldwideSebastian Walpole, Antonia L Pritchard, Colleen M Cebulla, et al.Pageof 1